Daihan Pharmaceutical Market Cap

Daihan Pharmaceutical has a market cap or net worth of 170.23 billion as of April 28, 2026. Its market cap has increased by 13.98% in one year.

Market Cap

170.23B

Enterprise Value

80.70B

Revenue

208.61B

Ranking

n/a

PE Ratio

6.16

Stock Price

29,050.00

Market Cap Chart

Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 170.23B, an increase of 664.72%. That is a compound annual growth rate of 8.42%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	170.23B	-1.03%
Dec 30, 2025	171.99B	11.64%
Dec 30, 2024	154.06B	-5.59%
Dec 28, 2023	163.17B	-11.13%
Dec 29, 2022	183.60B	6.62%
Dec 30, 2021	172.20B	-12.90%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hana Pharm	172.40B
Dongwha Pharm.Co.,Ltd	167.42B
Kyongbo Pharmaceutical	163.04B
Ilsung Is	162.38B
Whan In Pharm	196.48B
JW Lifescience	200.68B
REYON Pharmaceutical	201.38B
Jeil Pharmaceutical Co.,Ltd	202.54B

Market Cap Rankings